RecruitingNCT05115474

Study of Screening Brain MRIs in Stage IV Breast Cancer

Phase II Study of Screening Brain MRIs in Stage IV Breast Cancer


Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Enrollment

170 participants

Start Date

Dec 21, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The study is a single arm, nonrandomized phase II prospective study, with the goal of investigating the role of screening brain MRIs in neurologically asymptomatic patients with metastatic breast cancer.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is studying whether routinely checking for brain metastases (cancer that has spread to the brain) using MRI scans in people with stage IV (metastatic) breast cancer — even before symptoms appear — leads to better outcomes. Brain metastases are currently only detected when symptoms show up, but catching them earlier may allow earlier treatment. **You may be eligible if...** - You have been diagnosed with stage IV (metastatic) breast cancer, confirmed by biopsy - You know your ER, PR, and HER2 receptor status - For HR+/HER2- breast cancer: your disease must have progressed past first-line treatment - For HER2+ or triple-negative breast cancer: you must have confirmed stage IV disease - You are 18 or older with at least 6 months life expectancy - You have no prior brain metastases or treatment for brain cancer **You may NOT be eligible if...** - You have previously been diagnosed with or treated for brain metastases - You already have neurological symptoms that would normally prompt a brain MRI - You have advanced kidney disease that contraindicates MRI contrast dye - You have a medical condition that prevents MRI scanning Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMagnetic Resonance Imaging

Participants will undergo MRI imaging with and without contrast.


Locations(2)

Morton Plant Mease- Baycare

Clearwater, Florida, United States

Moffitt Cancer Center

Tampa, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05115474


Related Trials